Serum Institute of India is a company that manufactures vaccines and other pharmaceutical products. The company was founded in 1996 in Pune, Maharashtra, India.
Serum Institute of India claims to be the largest vaccine manufacturer by number of doses. They have produced and sold over 1.5 billion doses of vaccines around the world. The company has manufacture vaccines for Polio, Diphtheria, Tetanus, Perussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella diseases.
COVID-19
With the outbreak of COVID-19 (coronavirus), Serum Institute of India has claimed to have found a breakthrough in developing a vaccine for the contagion. Their virus-vaccine strain has reached animal clinical trial stages. They expect results from these trials within two months.
The company has partnered with a US-based biotech drug research company, Codagenix, to develop a vaccine to fight the coronavirus. The company claims it is the first vaccine to move from the laboratory to pre-clinical trial phase and they expect the product to be ready by 2022.
Timeline
People
Adar Poonawalla
CEO
Cyrus Poonawalla
Managing Director
Further reading
Serum Institute claims COVID-19 vaccine to be market ready by 2022
Web
Serum Institute of India | Manufacturer of Vaccines & immuno-biologicals - GMP Vaccine Manufacturer
Web
Serum Institute of India Pvt. Ltd. | Crunchbase
Web
Documentaries, videos and podcasts
Companies
Serum Institute of India
Adar Poonwalla
Pune, Maharashtra, India
Biotechnology, pharmaceuticals
